Cypress Point Wealth Management’s RenovoRx RNXT Stock Holding History

Cypress Point Wealth Management’s Portfolio RNXT Stock Details RNXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,000	Closed	-$20.2K	–	157
2026 Q1	$20.2K	Hold	20,000	–	–	﹤0.01%	123
2025 Q4	$16.8K	Buy	+20,000	New	+$20K	﹤0.01%	90

Other funds holding RNXT

ACA

Affinity Capital Advisors Berkeley, California $810M AUM 24.85% 1-Year Est. Return

MCRM

Midway Capital Research & Management Chicago, Illinois $126M AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Cypress Point Wealth Management's RNXT Position: Q2 2026 in Review

Cypress Point Wealth Management sold out of RenovoRx (RNXT) in Q2 2026, closing a stake of 20,000 shares — an estimated $20.2K sold.

Cypress Point Wealth Management first reported a position in RNXT in Q4 2025 and held it in 2 quarters. The position peaked at $20.2K in Q1 2026. 3 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

Cypress Point Wealth Management reported no remaining RenovoRx position as of Q2 2026 after selling out during the quarter.
Cypress Point Wealth Management sold 20,000 RenovoRx shares in Q2 2026, an estimated $20.2K.
Cypress Point Wealth Management first reported a position in RenovoRx in Q4 2025 and held it in 2 quarters.
Cypress Point Wealth Management's RenovoRx position peaked at $20.2K in Q1 2026.
3 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Cypress Point Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.